Clinical Researchers Adapting To Mandate For More Diversity In Study Populations

WASHINGTON -- Clinical investigators trying to include more women and minorities in their studies must rethink the traditional researcher-subject relationships and pay more attention to the needs of populations. And while the immediate costs of complying with federal mandates for increasing the use of underrepresented populations as research subjects may be significant, the long-term consequences of not doing so may be considerable, they say. "When I sit on committees, I hear members of re

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

"When I sit on committees, I hear members of renowned research institutions stressing the need to carefully separate research from service," says Janet Mitchell, director of the special prenatal clinic at Harlem Hospital in New York. "That's the old thinking: research has to be isolated and protected. But that won't hold water with these new populations."

Mitchell says today's researchers must be able to show how their science contributes to clients' welfare in addition to increasing the world's storehouse of knowledge. " Women, drug users, minorities--they're more sophisticated than the research establishment gives them credit for," says Mitchell. "Their question is, `What are you giving in return? I'm interested in helping if you show me how it'll help me or my children. If you only want me to get your data and your funds, I'm not coming.' " Critics of the use of homogeneous study populations in clinical research charge ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Marcia Clemmitt

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours